Mineralocorticoid Receptor Antagonists [MoA] - N0000000139

Name: Table of NDC products with mineralocorticoid receptor antagonists
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000000139
Pharmacologic Name	Mineralocorticoid Receptor Antagonists
Pharmacologic Uses	non-steroidal mineralocorticoid receptor antagonist (MRA)
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Mineralocorticoid Receptor Antagonists

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Mineralocorticoid Receptor Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50419-540	Kerendia	Non-Proprietary Name: Finerenone	Tablet, Film Coated	Oral	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
	50419-541	Kerendia	Non-Proprietary Name: Finerenone	Tablet, Film Coated	Oral	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE